Nebraska Medicine’s Blood and Bone Marrow Transplant program, established in 1983, is one of the world’s busiest, performing an average of 150 transplants annually.

This renowned center offers a comprehensive range of transplant types including autologous, allogeneic, and syngeneic transplants, addressing conditions like leukemia, lymphoma, and other hematologic disorders.

With a strong focus on continuous care and clinical research, Nebraska Medicine provides innovative treatments through its participation in national clinical trials networks, ensuring advanced care for patients.